Market Overview

Shire Issues Statement Regarding Media Speculation

Share:
Related
Earnings Scheduled For February 16, 2017
KemPharm CEO On Recent Results, Catalysts And Prospects: 'ADHD Is By Far The Larger Market Opportunity'
Cowen's Cacciatore doesn't see upside in Endo, cuts price target to $16; shares up 5% after Q4 beat (Seeking Alpha)

Shire plc ("Shire" or the "Company") (NASDAQ: SHPG) notes the
Bloomberg article this afternoon. Shire confirms it has held a meeting with
representatives of AbbVie.

This statement is being made by Shire without the prior agreement or approval
of AbbVie.

A further update will be made when appropriate. Shareholders are strongly
advised to take no action in relation to AbbVie's proposal. There can be no
certainty that any firm offer will be made nor as to the terms on which any
firm offer might be made.

Posted-In: News Press Releases

 

Related Articles (SHPG)

View Comments and Join the Discussion!